Literature DB >> 6201269

Combined modality approach in the management of locally advanced head and neck cancer.

C T Coughlin, M Grace, J F O'Donnell, P J LeMarbre, W D Morain, N A Geurkink, O R McIntyre.   

Abstract

Twenty-five patients with stage III or IV locally advanced head and neck cancer were treated from February 1981 to November 1982 with a combined modality approach utilizing chemotherapy followed by irradiation and surgery. Induction therapy with cisplatin and bleomycin was followed by a sequence integrating weekly cisplatin into a program of locoregional irradiation. After the administration of 4800 cGy, patients received either "boost" irradiation or surgery. At the completion of all therapy, 20 of 23 patients evaluable for response had achieved complete remission. Toxicity was tolerable and all patients are being followed closely to assess durability of remission and overall survival.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201269

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  3 in total

1.  Chemotherapy in head and neck cancer with bleomycin, cisplatinum, and methotrexate.

Authors:  T Deitmer; D Urbanitz
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 2.  Chemotherapeutic management of head and neck cancer.

Authors:  M Al-Sarraf
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Response of an ocular melanoma to subconjunctival injection of 5-thio-D-glucose or cis-platin.

Authors:  K A Skov; C Kumi; J Rootman; N Bussanich; M O Fellenz
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.